Inventor · disambiguated record
Antony N. Shaw
Also filed as: SHAW ANTONY · SHAW ANTONY N · SHAW ANTONY NICHOLAS
15 granted patents·15 pending applications·229 citations·filing 1992–2023
94Inventor score
Files withGLAXOSMITHKLINE LLC10SMITHKLINE BEECHAM CORP7DUFFY KEVIN J5ADAMS NICHOLAS D1BRACKLEY III JAMES A1
Top patents by PatentIndex Score
30 records- 0193US7332481B2Thrombopoietin mimeticsSMITHKLINE BEECHAM CORP·Filed 2007·Granted Feb 19, 2008·20 cites·26 claims
- 0292US8324208B2Prolyl hydroxylase inhibitorsDUFFY KEVIN J·Filed 2007·Granted Dec 4, 2012·19 cites·16 claims
- 0390US11643397B2Prolyl hydroxylase inhibitorsGLAXOSMITHKLINE LLC·Filed 2021·Granted May 9, 2023·1 cites·4 claims
- 0490US8815884B2Prolyl hydroxylase inhibitorsGLAXOSMITHKLINE LLC·Filed 2013·Granted Aug 26, 2014·9 cites·9 claims
- 0590US8557834B2Prolyl hydroxylase inhibitorsGLAXOSMITHKLINE LLC·Filed 2012·Granted Oct 15, 2013·8 cites·2 claims
- 0690US5447954APhenylderivate as inhibitors of ATP citrate lyaseSMITHKLINE BEECHAM PLC·Filed 1992·Granted Sep 5, 1995·111 cites·10 claims
- 0789US6720345B1Semicarbazone derivatives and their use as thrombopoietin mimeticsSMITHKLINE BEECHAM CORP·Filed 2000·Granted Apr 13, 2004·24 cites·11 claims
- 0886US10035779B2Prolyl hydroxylase inhibitorsGLAXOSMITHKLINE LLC·Filed 2016·Granted Jul 31, 2018·3 cites·14 claims
- 0986US7674887B2Thrombopoietin mimeticsGLAXOSMITHKLINE LLC·Filed 2008·Granted Mar 9, 2010·5 cites·4 claims
- 1085US10336711B2Prolyl hydroxylase inhibitorsGLAXOSMITHKLINE LLC·Filed 2018·Granted Jul 2, 2019·2 cites·28 claims
- 1185US2023227414A1Prolyl Hydroxylase InhibitorsGLAXOSMITHKLINE LLC·Filed 2023·Application pending·0 cites
- 1284US6875786B2Thrombopoietin mimeticsSMITHKLINE BEECHAM CORP·Filed 2002·Granted Apr 5, 2005·14 cites·10 claims
- 1382US7608621B2N-substituted glycine derivatives: hydroxylase inhibitorsSMITHKLINE BEECHAM CORP·Filed 2008·Granted Oct 27, 2009·6 cites·10 claims
- 1480US7452874B2Thrombopoietin mimeticsSMITHKLINE BEECHAM CORP·Filed 2007·Granted Nov 18, 2008·2 cites·18 claims
- 1577USRE44613EN-substituted glycine derivatives: hydroxylase inhibitorsDUFFY KEVIN J·Filed 2011·Granted Nov 26, 2013·4 cites·26 claims
- 1672US2020157055A1Prolyl Hydroxylase InhibitorsGLAXOSMITHKLINE LLC·Filed 2019·Application pending·0 cites
- 1767US2014336383A1Prolyl hydroxylase inhibitorsGLAXOSMITHKLINE LLC·Filed 2014·Application pending·0 cites
- 1861US7241783B2Thrombopoietin mimeticsLIGAND PHARMACEUTICAL·Filed 2001·Granted Jul 10, 2007·1 cites·1 claims
- 1960US2015315157A1Prolyl hydroxylase inhibitorsGLAXOSMITHKLINE LLC·Filed 2015·Application pending·0 cites
- 2056US2013078213A1Thrombopoietin mimeticsDUFFY KEVIN J·Filed 2012·Application pending·0 cites
- 2152US2011160227A1Prolyl Hydroxylase InhibitorsSHAW ANTONY·Filed 2009·Application pending·0 cites
- 2250US2011098324A1Prolyl hydroxylase inhibitorsBRACKLEY III JAMES A·Filed 2009·Application pending·0 cites
- 2348US2008171756A1N-Substituted Glycine Derivatives: Prolyl Hydroxylase InhibitorsSHAW ANTONY N·Filed 2008·Application pending·0 cites
- 2446US2008214455A1Novel Chemical CompoundsSMITHKLINE BEECHAM CORP·Filed 2006·Application pending·0 cites
- 2544US2008262027A1Novel Chemical CompoundsDUFFY KEVIN J·Filed 2006·Application pending·0 cites
- 2643US2009203692A1Novel chemical compoundsSMITHKLINE BEECHAM CORP·Filed 2006·Application pending·0 cites
- 2742US2007249599A1Novel Chemical CompoundsDUFFY KEVIN J·Filed 2005·Application pending·0 cites
- 2841US2008176830A1Compounds, Compositions, and MethodsADAMS NICHOLAS D·Filed 2006·Application pending·0 cites
- 2937US2013225524A1Chemical CompoundsCHAI DEPING·Filed 2011·Application pending·0 cites
- 3037US2004147739A1Novel anti-infectivesFiled 2002·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →